Drugs & Targets FDA grants breakthrough designation for Rina-S in advanced endometrial cancer September 05, 2025Vol.51 No.32
Drugs & Targets ColoAlert colorectal screening test receives approval in Switzerland September 05, 2025Vol.51 No.32
Capitol Hill GOP-led Congress rejects Trump’s plans to gut medical researchSenate bill gives NIH a $400 million raise August 01, 2025Vol.51 No.30By Paul Goldberg
News Analysis Vinay Prasad falls from grace at FDA upon flunking Trump political purity testMAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? August 01, 2025Vol.51 No.30By Claire Marie Porter
U.S. News & World Report expands evaluation of outcomes in cancer subspecialties August 01, 2025Vol.51 No.30By Sara Willa Ernst
Guest Editorial USPSTF doesn’t lean right or left—it’s about data, not politics August 01, 2025Vol.51 No.30By Barnett Kramer
Cancer Policy UPenn study supports continued use of ODAC voting August 01, 2025Vol.51 No.30By Jacquelyn Cobb
In Brief Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards August 01, 2025Vol.51 No.30
